UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000039888
Receipt No. R000045491
Scientific Title Impact of sacopenia and activities of daily living in patients with hip fractures
Date of disclosure of the study information 2020/03/20
Last modified on 2020/03/20 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Impact of sacopenia and activities of daily living in patients with hip fractures
Acronym Impact of sacopenia and ADL in patients with hip fractures
Scientific Title Impact of sacopenia and activities of daily living in patients with hip fractures
Scientific Title:Acronym Impact of sacopenia and activities of ADL in patients with hip fractures
Region
Japan

Condition
Condition femoral neck fracture
Classification by specialty
Orthopedics Rehabilitation medicine Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the relationship between the actual condition of sarcopenia and ADL at discharge in patients with proximal femoral fracture.
Basic objectives2 Others
Basic objectives -Others Sarcopenia accounts for approximately 20 ~ 50% of proximal femoral fractures and is associated with a high risk of QOL deterioration and frailty. Therefore, rehabilitation requires not only measures against functional impairment but also measures against sarcopenia.
However, the status of sarcopenia in the perioperative period and the relationship between sarcopenia and rehabilitation outcome are unclear. In this study, we investigated the actual condition of sarcopenia and factors affecting ADL in patients with proximal femoral fracture.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Barthel index efficacy
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
65 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria Patients aged 65 years or older undergoing surgery and postoperative rehabilitation at our hospital for proximal femoral fracture
Key exclusion criteria Patients with serious complications who were unable to walk or died before the injury
Target sample size 42

Research contact person
Name of lead principal investigator
1st name Takako
Middle name
Last name Nagai
Organization Nihon university hospital
Division name Orthpedic surgery
Zip code 101-8309
Address 1-6, kanda surugadai, Chiyoda-ku,Tokyo
TEL 03-3293-1711
Email ntnyf092@yahoo.co.jp

Public contact
Name of contact person
1st name Takako
Middle name
Last name Nagai
Organization Nihon University hospital
Division name Orthpedic surgery
Zip code 101-8309
Address 1-6, kanda surugadai, Chiyoda-ku,Tokyo
TEL 03-3293-1711
Homepage URL
Email ntnyf092@yahoo.co.jp

Sponsor
Institute Nihon University hospital
Institute
Department

Funding Source
Organization Nihon University hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Nihon University hospital
Address 1-6, kanda surugadai, Chiyoda-ku,Tokyo
Tel 03-3293-1711
Email ntnyf092@yahoo.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 03 Month 20 Day

Related information
URL releasing protocol
Publication of results Published

Result
URL related to results and publications
Number of participants that the trial has enrolled 42
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Main results already published
Date of protocol fixation
2018 Year 06 Month 01 Day
Date of IRB
2019 Year 12 Month 12 Day
Anticipated trial start date
2018 Year 06 Month 01 Day
Last follow-up date
2019 Year 06 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information There were 28 patients in the sarcopenia group and 14 patients in the non-sarcopenia group. Univariate analysis revealed significant differences in age, body weight, body mass index (BMI), and dementia. In the correlation between BI gain and each value in Spearman's rank correlation coefficient, GNRI and BI at discharge showed positive correlation, and negative correlation in age, sarcopenia, CCI, PIMs, and cognitive function. Multiple regression analysis using BI at discharge as the dependent variable revealed that age and PIMs were significant associated factors.

Management information
Registered date
2020 Year 03 Month 20 Day
Last modified on
2020 Year 03 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045491